Search Results - "Goehler, Karin"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users: A Phase 1 Randomized Controlled Study

    Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users: A Phase 1 Randomized Controlled Study by Göhler, Karin, Sokolowska, Marta, Schoedel, Kerri A, Nemeth, Robert, Kleideiter, Elke, Szeto, Isabella, Eerdekens, Marie-Henriette

    Published in Journal of clinical psychopharmacology (01-01-2019)
    “…Cebranopadol is a nociceptin/orphanin FQ peptide/opioid receptor agonist with central antinociceptive activity. We hypothesize that this novel mechanism of…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Who is a ‘healthy subject’?—consensus results on pivotal eligibility criteria for clinical trials

    Who is a ‘healthy subject’?—consensus results on pivotal eligibility criteria for clinical trials by Breithaupt-Groegler, Kerstin, Coch, Christoph, Coenen, Martin, Donath, Frank, Erb-Zohar, Katharina, Francke, Klaus, Goehler, Karin, Iovino, Mario, Kammerer, Klaus Peter, Mikus, Gerd, Rengelshausen, Jens, Sourgens, Hildegard, Schinzel, Reinhard, Sudhop, Thomas, Wensing, Georg

    Published in European Journal of Clinical Pharmacology (01-04-2017)
    “…Introduction/Methods A discussion forum was hosted by the German not-for-profit Association for Applied Human Pharmacology (AGAH e.V.) to critically review key…”
    Get full text
    Journal Article Book Review
    Save to List
    Saved in:
  3. 3
    Comparative pharmacokinetics and bioavailability of tapentadol following oral administration of immediate- and prolonged-release formulations

    Comparative pharmacokinetics and bioavailability of tapentadol following oral administration of immediate- and prolonged-release formulations by GÖHLER, Karin, BRETT, Martin, SMIT, Johan W, RENGELSHAUSEN, Jens, TERLINDEN, Rolf

    “…To evaluate the bioavailability and pharmacokinetics of orally administered tapentadol immediate release (IR) compared with tapentadol prolonged release (PR)…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Pharmacokinetics of chlormadinone acetate following single and multiple oral dosing of chlormadinone acetate (2 mg) and ethinylestradiol (0.03 mg) and elimination and clearance of a single dose of radiolabeled chlormadinone acetate

    Pharmacokinetics of chlormadinone acetate following single and multiple oral dosing of chlormadinone acetate (2 mg) and ethinylestradiol (0.03 mg) and elimination and clearance of a single dose of radiolabeled chlormadinone acetate by Terlinden, Rolf, Uragg, Heinz, Göhler, Karin, Kneip, Christa

    Published in Contraception (Stoneham) (01-09-2006)
    “…Published data on pharmacokinetic parameters for chlormadinone acetate (CMA) are in part contradictory, especially with regard to terminal half-life ( t 1/2, z…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Multiple-dose pharmacokinetics and excretion balance of gatifloxacin, a new fluoroquinolone antibiotic, following oral administration to healthy Caucasian volunteers

    Multiple-dose pharmacokinetics and excretion balance of gatifloxacin, a new fluoroquinolone antibiotic, following oral administration to healthy Caucasian volunteers by Mignot, Alain, Guillaume, Michel, Brault, Muriel, Gualano, Virginie, Millérioux, Laurette, Göhler, Karin, Stahlberg, Hans-Jüergen

    Published in Chemotherapy (Basel) (01-07-2002)
    “…The multiple-dose pharmacokinetics and excretion balance of gatifloxacin were evaluated in 42 healthy Caucasian volunteers. Following multiple oral doses of…”
    Get more information
    Journal Article
    Save to List
    Saved in:

Search Tools: